Whitefort Capital Management, Lp Top Holdings and 13F Report (2026) About Whitefort Capital Management, LpInvestment ActivityWhitefort Capital Management, Lp has $339.09 million in total holdings as of March 31, 2026.Whitefort Capital Management, Lp owns shares of 20 different stocks, but just 9 companies or ETFs make up 80% of its holdings.Approximately 11.67% of the portfolio was purchased this quarter.About 27.62% of the portfolio was sold this quarter.This quarter, Whitefort Capital Management, Lp has purchased 19 new stocks and bought additional shares in 6 stocks.Whitefort Capital Management, Lp sold shares of 4 stocks and completely divested from 2 stocks this quarter.Largest Holdings Arbutus Biopharma $67,188,983Roivant Sciences $39,306,300JOYY $30,651,480SABLE OFFSHORE CORP $25,519,980Genworth Financial $25,418,044 Largest New Holdings this Quarter 74467Q103 - PubMatic $5,644,200 Holding69002R103 - Outbrain $2,377,614 Holding65345N106 - NextNav $971,693 Holding Largest Purchases this Quarter Arbutus Biopharma 1,587,657 shares (about $7.14M)JOYY 120,000 shares (about $7.01M)PubMatic 690,000 shares (about $5.64M)Genworth Financial 590,000 shares (about $4.79M)BALLYS CORPORATION 486,691 shares (about $4.69M) Largest Sales this Quarter Roivant Sciences 701,000 shares (about $19.42M)USA TODAY CO INC 1,650,000 shares (about $11.63M)SABLE OFFSHORE CORP 366,000 shares (about $6.05M)SPDR Gold Shares 2,600 shares (about $1.12M) Sector Allocation Over TimeMap of 500 Largest Holdings ofWhitefort Capital Management, Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorABUSArbutus Biopharma$67,188,983$7,144,457 â–²11.9%14,930,88519.8%MedicalROIVRoivant Sciences$39,306,300$19,417,700 â–¼-33.1%1,419,00011.6%MedicalYYJOYY$30,651,480$7,006,800 â–²29.6%524,9449.0%Computer and TechnologySABLE OFFSHORE CORP$25,519,980$6,046,320 â–¼-19.2%1,544,7937.5%COM SHSGNWGenworth Financial$25,418,044$4,790,800 â–²23.2%3,130,3017.5%FinanceBALLYS CORPORATION$23,213,727$4,691,701 â–²25.3%2,408,0636.8%COMMON STOCKOABIOmniAb$22,331,1430.0%14,223,6586.6%MedicalUSA TODAY CO INC$22,030,073$11,632,500 â–¼-34.6%3,124,8336.5%COMCDZICadiz$19,575,2960.0%3,986,8225.8%Consumer StaplesOPKO HEALTH INC$11,640,7500.0%9,350,0003.4%NOTE 3.75% 1/1SGRYSurgery Partners$10,860,741$3,708,741 â–²51.9%911,1363.2%MedicalQUREuniQure$10,751,940$3,247,290 â–²43.3%657,6113.2%MedicalGLDSPDR Gold Shares$10,499,076$1,118,754 â–¼-9.6%24,4003.1%FinancePUBMPubMatic$5,644,200$5,644,200 â–²New Holding690,0001.7%Computer and TechnologyOPKOPKO Health$4,848,8080.0%4,253,3401.4%MedicalINNOVATE CORP$4,220,2400.0%743,0001.2%COM NEWOBOutbrain$2,377,614$2,377,614 â–²New Holding3,610,1030.7%Business ServicesKESTREL GROUP LTD$1,737,8930.0%160,9160.5%COMNNNextNav$971,693$971,693 â–²New Holding60,6550.3%Business ServicesNNAVWNextNav$299,1810.0%47,2640.1%Computer and TechnologyMRNAModerna$0$29,490,000 â–¼-100.0%00.0%MedicalLQDALiquidia$0$25,960,623 â–¼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
